Project Grant R21AT013617
- Federal Grant Award Summary The National Center for Complementary and Integrative Health (NCCIH) awarded a Project Grant of $787,346 to The Leland Stanford Junior University on April 13, 2026, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The research, conducted in Palo Alto, California, and scheduled for completion by December 31, 2030, addresses the restoration of key microbial functions in industrialized gut microbiomes. The project focuses...
- Federal Grant Award Summary The University of California, San Diego received a $439,500 Project Grant from the National Center for Complementary and Integrative Health under the Research and Training in Complementary and Integrative Health program (CFDA 93.213) for the period April 1, 2026 through March 31, 2028. The award supports the development of advanced technologies and methodologies to enable high-resolution structural analysis of native polyketide synthase (PKS) megasynthases using...
- This Project Grant award from the National Center for Complementary and Integrative Health (NCCIH) under CFDA 93.213 - Research and Training in Complementary and Integrative Health provides $451,000.00 in funding to The Trustees of Princeton University from September 2024 to August 2026. The objective is to characterize the secondary metabolomes of three Corynebacterial strains, including uncovering the small molecule products they use to compete with other microbes and interact with host cells....
- This Project Grant award from the National Center for Complementary and Integrative Health (NCCIH) under CFDA Program 93.213 - Research and Training in Complementary and Integrative Health, provides $506,000.00 in funding to the Scripps Research Institute in La Jolla, CA from September 13, 2024 to August 31, 2026. The award supports research to develop orally available recombinant peptidoglycan hydrolase therapeutics that can promote intestinal barrier function and protect against enteric...
- Federal Project Grant Award Summary The University of California, San Francisco received a $601,259 Project Grant from the National Center for Complementary and Integrative Health (NCCIH) under the Research and Training in Complementary and Integrative Health program (CFDA 93.213), awarded April 17, 2026, with completion targeted for March 31, 2029. This research initiative will assess the multi-site feasibility of an integrated treatment combining whole-body hyperthermia (WBH) and cognitive...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $353,500 under the Biomedical Research and Research Training program (CFDA 93.859) to the Regents of the University of California at Riverside for a Project Grant commencing September 1, 2025, and concluding June 30, 2030. The research initiative investigates how xenobiotic exposure—including non-antibiotic drugs, pesticides, and plasticizers—affects gut microbiome composition, metabolism, and...
- Federal Project Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $422,931 to the University of Colorado-Denver on July 1, 2025, under the Biomedical Research and Research Training program (CFDA 93.859) to support research characterizing natural product-mediated microbial interactions. Through this five-year project (concluding April 30, 2030), the awardee will integrate cheminformatics analysis of untargeted metabolomics data with physiologically relevant in...
- Federal Project Grant Award Summary The National Institutes of Health (NIH) Office of the Director awarded a $1.23 million Project Grant under the Trans-NIH Research Support program (CFDA 93.310) to the University of California, Irvine on August 15, 2025. This three-year award (through July 31, 2028) supports the development of chemical glycobiology tools to decipher host-microbiota interactions, with focus on understanding how microbial exo- and capsular polysaccharides modulate host...
- Federal Grant Award Summary The Scripps Research Institute received $831,984 in Project Grant funding from the National Center for Complementary and Integrative Health (NCCIH) under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The award, initiated April 17, 2026 with completion targeted for January 31, 2031, supports fundamental neuroscience research to elucidate the neural mechanisms underlying the co-regulation of emotional and autonomic responses....
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded $532,500 through the Biomedical Research and Research Training program (CFDA 93.859) to University Enterprises, Inc. (doing business as Sacramento State Sponsored Research) for a three-year project spanning September 1, 2025, through August 31, 2028. The project investigates the function and evolution of bacterial strains within the human gut microbiota, specifically focusing on Paraclostridium...
The National Center for Complementary and Integrative Health (NCCIH) awarded a $428,855 Project Grant to the University of California, San Diego effective April 1, 2026 through March 31, 2028, under the Research and Training in Complementary and Integrative Health program (CFDA 93.213). The award funds an integrated computational and experimental research initiative to develop novel approaches for precision microbiota transplantation therapies. The project addresses critical gaps in fecal microbiota transplantation (FMT) by developing predictive models and experimental pipelines to identify microbial communities capable of stable engraftment in individual patients. Specifically, the research will employ metabolic modeling and statistical classifiers to extract metabolic features from microbial communities and predict FMT outcomes, as well as develop culturomics-based strategies to profile unused metabolic niches within recipient microbiomes and introduce donor-derived communities matched to those niches. The deliverables include a novel computational framework for donor-recipient matching and an experimental pipeline to identify niche-associated microbial communities suitable for engraftment. These products are designed to overcome colonization resistance—a primary barrier to successful FMT—by identifying "orthogonal" donor consortia whose metabolic requirements differ from recipient microbiota, thereby reducing metabolic competition and improving therapeutic efficacy. The research will be validated through both murine and human cohorts, providing evidence-based tools to enable clinicians to accurately predict FMT outcomes and systematically introduce therapeutic microbiota into variable patient microbiomes.Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $428.9k | 3/26/26 |